ImmuCell Corporation (ICCC)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $103.82M
Last updated: Nov 17, 2026 at 4:10 PM ET
ImmuCell Corporation (ICCC) Stock Chart
ImmuCell (ICCC) has a latest price of $11.33 on Nov 17, 2026, 6.4% below its 52-week high of $12.10. Its price rose 109.8% over the past 12 months. The month-end price rose 83.5% over the 10 years through Oct 2026, a compound annual rate of 6.3%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $11.21 in Jul 2026 and its lowest $3.61 in Oct 2024, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart ICCC with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ICCC.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 11.8%, and over 6 months it rose 11.1%. The month-end price rose 103.2% over the 3 years through Oct 2026, a compound annual rate of 26.7%.
| Period | Change |
|---|---|
| 1 month | +7.8% |
| 3 months | +11.8% |
| 6 months | +11.1% |
| 12 months | +109.8% |
| 12 months, with dividends | +109.8% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +103.2% | +26.7% |
| 5 years | +16.6% | +3.1% |
| 10 years | +83.5% | +6.3% |
Price by Year
Its best calendar year was 2017, when the price rose 47.7%, and its weakest was 2019, when it fell 26.9%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $10.26 | +66.8% |
| 2025 | $6.15 | +19.4% |
| 2024 | $5.15 | +1.2% |
| 2023 | $5.09 | -16.6% |
| 2022 | $6.10 | -23.8% |
| 2021 | $8.00 | +34.5% |
| 2020 | $5.95 | +15.5% |
| 2019 | $5.15 | -26.9% |
| 2018 | $7.05 | -19.8% |
| 2017 | $8.79 | +47.7% |
Trading Range
The price is 11.5% above its 50-day average of $10.16 and 24.4% above its 200-day average of $9.11.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $11.33 | |
| 52-week high | $12.10 | -6.4% |
| 52-week low | $4.52 | +150.7% |
| 50-day average | $10.16 | +11.5% |
| 200-day average | $9.11 | +24.4% |
Price Risk
Over 3 years, its largest fall from a peak was 40.0%.
| Measure | Value |
|---|---|
| 1-year beta | 0.31 |
| Largest fall, 1 year | -18.3% |
| Largest fall, 3 years | -40.0% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About ICCC
What is ICCC's 1-year price change?
ImmuCell's price rose 109.8% over the past 12 months. With dividends included, the 12-month total return was 109.8%.
What is ICCC's 5-year price change?
ImmuCell's month-end price rose 16.6% over the 5 years through Oct 2026, a compound annual rate of 3.1%. These figures leave out dividends.
What is ICCC's 52-week high and low?
ImmuCell's 52-week high is $12.10 and its 52-week low is $4.52. Its latest price of $11.33 on Nov 17, 2026 is 6.4% below the high.
What is ICCC's beta?
ImmuCell's 1-year beta against the S&P 500 is 0.31, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 18.3%.
Is the ICCC chart free?
Yes. Advanced Charting for ICCC is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
ICCC pages: Overview, Charting, Earnings, Financials, Statistics, Valuation, Competitors